Dr. Lal PathLabs Limited

NSEI:LALPATHLAB Voorraadrapport

Marktkapitalisatie: ₹253.4b

Dr. Lal PathLabs Dividenden en inkoop

Dividend criteriumcontroles 3/6

Dr. Lal PathLabs is een dividendbetalend bedrijf met een huidig rendement van 0.59% dat ruimschoots wordt gedekt door de winst. Volgende betalingsdatum is op 22nd November, 2024 met een ex-dividenddatum van 5th November, 2024.

Belangrijke informatie

0.6%

Dividendrendement

-0.03%

Terugkoop Rendement

Totaal aandeelhoudersrendement0.6%
Toekomstig dividendrendement1.0%
Dividendgroei9.0%
Volgende betaaldatum dividend22 Nov 24
Ex-dividenddatum05 Nov 24
Dividend per aandeel₹18.000
Uitbetalingsratio62%

Recente updates van dividend en inkoop

Recent updates

Analysts Are Updating Their Dr. Lal PathLabs Limited (NSE:LALPATHLAB) Estimates After Its Second-Quarter Results

Oct 26
Analysts Are Updating Their Dr. Lal PathLabs Limited (NSE:LALPATHLAB) Estimates After Its Second-Quarter Results

Capital Investment Trends At Dr. Lal PathLabs (NSE:LALPATHLAB) Look Strong

Oct 24
Capital Investment Trends At Dr. Lal PathLabs (NSE:LALPATHLAB) Look Strong

Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) Share Price Could Signal Some Risk

Oct 06
Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) Share Price Could Signal Some Risk

These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely

Jul 28
These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely

We Think Dr. Lal PathLabs' (NSE:LALPATHLAB) Profit Is Only A Baseline For What They Can Achieve

May 21
We Think Dr. Lal PathLabs' (NSE:LALPATHLAB) Profit Is Only A Baseline For What They Can Achieve

What Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) P/E Is Not Telling You

May 01
What Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) P/E Is Not Telling You

Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital

Apr 13
Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital

These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely

Mar 06
These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely

Dr. Lal PathLabs Limited Just Missed EPS By 5.4%: Here's What Analysts Think Will Happen Next

Feb 04
Dr. Lal PathLabs Limited Just Missed EPS By 5.4%: Here's What Analysts Think Will Happen Next

Subdued Growth No Barrier To Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) Price

Dec 28
Subdued Growth No Barrier To Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) Price

Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?

Nov 17
Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?

Dr. Lal PathLabs (NSE:LALPATHLAB) Will Be Hoping To Turn Its Returns On Capital Around

Oct 12
Dr. Lal PathLabs (NSE:LALPATHLAB) Will Be Hoping To Turn Its Returns On Capital Around

Here's Why Dr. Lal PathLabs (NSE:LALPATHLAB) Can Manage Its Debt Responsibly

Jul 07
Here's Why Dr. Lal PathLabs (NSE:LALPATHLAB) Can Manage Its Debt Responsibly

Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital

Jun 10
Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital

Dr. Lal PathLabs (NSE:LALPATHLAB) Could Be Struggling To Allocate Capital

Feb 13
Dr. Lal PathLabs (NSE:LALPATHLAB) Could Be Struggling To Allocate Capital

Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?

Dec 29
Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?

Dr. Lal PathLabs (NSE:LALPATHLAB) Will Want To Turn Around Its Return Trends

Sep 21
Dr. Lal PathLabs (NSE:LALPATHLAB) Will Want To Turn Around Its Return Trends

These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Reasonably Well

Sep 01
These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Reasonably Well

Dr. Lal PathLabs (NSE:LALPATHLAB) Will Pay A Dividend Of ₹6.00

Jul 31
Dr. Lal PathLabs (NSE:LALPATHLAB) Will Pay A Dividend Of ₹6.00

Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital

Jun 23
Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital

Does This Valuation Of Dr. Lal PathLabs Limited (NSE:LALPATHLAB) Imply Investors Are Overpaying?

Jun 11
Does This Valuation Of Dr. Lal PathLabs Limited (NSE:LALPATHLAB) Imply Investors Are Overpaying?

Stabiliteit en groei van betalingen

Dividenden ophalen

Stabiel dividend: LALPATHLAB betaalt al minder dan 10 jaar dividend en gedurende deze periode zijn de betalingen volatiel geweest.

Groeiend dividend: De dividendbetalingen van LALPATHLAB zijn gestegen, maar het bedrijf heeft pas 8 jaar dividend uitgekeerd.


Dividendrendement versus markt

Dr. Lal PathLabs Dividendrendement versus markt
Hoe verhoudt LALPATHLAB dividendrendement zich tot de markt?
SegmentDividendrendement
Bedrijf (LALPATHLAB)0.6%
Markt onderkant 25% (IN)0.3%
Markt Top 25% (IN)1.1%
Gemiddelde industrie (Healthcare)0.3%
Analist prognose (LALPATHLAB) (tot 3 jaar)1.0%

Opmerkelijk dividend: Het dividend van LALPATHLAB ( 0.59% ) is hoger dan dat van de onderste 25% van de dividendbetalers op de Indian markt ( 0.25% ).

Hoog dividend: Het dividend LALPATHLAB ( 0.59% ) is laag vergeleken met de top 25% van dividendbetalers in de Indian markt ( 1.14% ).


Winstuitkering aan aandeelhouders

Verdiendekking: Met zijn redelijke payout ratio ( 62.2% ) worden de dividendbetalingen van LALPATHLAB gedekt door de winst.


Contante uitbetaling aan aandeelhouders

Kasstroomdekking: Met zijn redelijk lage cash payout ratio ( 30.5% ) worden de dividendbetalingen van LALPATHLAB goed gedekt door de kasstromen.


Ontdek bedrijven met een sterk dividend